Skip to main content

Table 1 HLA class I expression levels and characteristics of the patients (stage II colorectal cancer)

From: Prognostic value of HLA class I expression in patients with colorectal cancer

 

Positive

Dull and negative

Total

P value

( n= 51; 53%)

( n= 46; 47%)

( n= 97)

Stage

   

0.54

 Stage IIA

46 (90)

42 (91)

88

 

 Stage IIB

2 (4)

0 (0)

2

 

 Stage IIC

3 (6)

4 (9)

7

 

Age (years)

   

0.11

 Mean ± SD

64 ± 9.7

60 ± 12.3

  

 Range

42 ~ 80

31 ~ 83

  

Gender—no. of patients (%)

   

0.03

 Male

27 (53%)

34 (74%)

61

 

 Female

24 (47%)

12 (26%)

36

 

Diameter of primary tumor (mm)—no. (%)

   

0.87

30

11 (22%)

12 (26%)

23

 

 31–50

21 (41%)

17 (37%)

38

 

51

19 (37%)

17 (37%)

36

 

Location—no. of patients (%)

   

0.84

 Right

16 (31%)

13 (28%)

29

 

 Left

15 (30%)

16 (35%)

31

 

 Rectum

20 (39%)

17 (37%)

37

 

Histological type—no. (%)

   

0.23

 Well/mod

48 (94%)

40 (87%)

88

 

 Por/muc

3 (6%)

6 (13%)

9

 

Lymphatic invasion—no. of patients (%)

   

0.55

 Negative

45 (88%)

40 (87%)

85

 

 Positive

6 (12%)

6 (13%)

12

 

Venous invasion—no. of patients (%)

   

0.33

 Negative

44 (86%)

42 (91%)

86

 

 Positive

7 (14%)

4 (9%)

11